Liver cancer is the ®fth most common cancer worldwide and unlike certain other cancers, such as colon cancer, a mutational model has not yet been developed. We have performed gene expression pro®ling of normal and neoplastic livers in C3H/HeJ mice treated with diethylnitrosamine. Using oligonucleotide microarrays, we compared gene expression in liver tumors to three dierent states of the normal liver: quiescent adult, regenerating adult, and newborn. Although each comparison revealed hundreds of dierentially expressed genes, only 22 genes were found to be deregulated in the tumors in all three comparisons. Three of these genes were examined in human hepatocellular carcinomas and were found to be upregulated. As a second method of analysis, we used Representational Dierence Analysis (RDA) to clone mRNA fragments dierentially expressed in liver tumors versus regenerating livers. We cloned several novel mRNAs that are dierentially regulated in murine liver tumors. Here we report the sequence of a novel cDNA whose expression is upregulated in both murine and human hepatocellular carcinomas. Our results suggest that DEN-treated mice provide an excellent model for human hepatocellular carcinomas. Oncogene (2001) 20, 2704 ± 2712.
Introduction
Liver cancer is the ®fth most common cancer worldwide with 437 000 cases reported in 1990 (Parkin et al., 1999) with hepatocellular carcinomas (HCC) accounting for 85% of liver cancer cases. Several risk factors have been correlated with the development of liver cancer, such as hepatitis B and C infection and exposure to a¯atoxin b1. Accordingly, the occurrence of liver cancer is highest in areas of Asia and Africa where the population shows a high prevalence of hepatitis B and C infection (Bosch et al., 1999) . Unlike other cancers such as skin and colon, a clear mutational model has not been developed for liver cancer and there is currently a lack of successful treatment options. The identi®cation of speci®c genes that are deregulated in liver cancer is a critical ®rst step in developing a successful strategy for the treatment of liver cancer.
In an eort to address these questions, we attempted to identify genes that show dierential expression in liver tumors as compared to normal liver tissue. We used C3H/HeJ male mice due to their high susceptibility to diethylnitrosamine (DEN)-induced liver tumors. In this study, the liver tumors were classi®ed as hepatomas (mixed types A and B). We compared gene expression pro®les in liver tumors to three dierent models of normal proliferation: the quiescent liver, regenerating liver and newborn liver. It is likely that many genes are dierentially expressed in a quiescent liver when compared to a liver tumor; however, our goal was to identify genes which are critical to the development of the tumor and not just a consequence of increased proliferation. Because of the unique proliferative abilities of the liver in response to injury, such as partial hepatectomy, we have been able to compare gene expression in nonneoplastic proliferating livers to liver tumors. Finally, because HCC often presents gene expression pro®les characteristic of less dierentiated hepatocytes (Kojiro and Nakashima, 1999) , we have also compared the tumors to newborn livers. We utilized two methods, each with distinct advantages and disadvantages, to assess gene expression changes in liver tumors. We began by using oligonucleotide microarrays due to their ability to detect modest changes in gene expression and their ability to easily compare multiple samples. Using this approach we were able to examine the mRNA expression of 6500 murine genes in three pairwise comparisons of liver tumors to quiescent, regenerating, and newborn livers. However, oligonucleotide arrays do not detect genes at extremely low levels or genes whose probes are absent from the microarray cannot be detected. Therefore, we also examined gene expression dierences between liver tumors and regenerating livers using RDA. As reported below, the combination of these two techniques is an eective method for identifying gene expression alterations in liver cancer and for isolating previously unknown tumor-speci®c genes.
Results

Identification of gene expression alterations in liver tumors with oligonucleotide microarrays
To analyse gene expression alterations during hepatocarcinogenesis, we used oligonucleotide microarrays to compare gene expression pro®les of 6500 murine genes in liver tumors to three states of normal proliferation: quiescent liver, regenerating liver and newborn liver. A comparison of liver tumors to quiescent livers identi®ed genes whose expression was altered after neoplastic transformation. The comparison of liver tumors to two normal states of proliferation, the regenerating and newborn livers allowed the identi®cation of genes that are tumor-speci®c as opposed to proliferation-speci®c. As a control, we also compared gene expression in quiescent livers to regenerating livers; as expected, we observed several genes, such as cdc2 and cyclin B2, whose expression was increased 65-and ®vefold respectively, in the regenerating liver (data not shown). Information about all genes that showed a greater than 2.5-fold dierence in each comparison can be found on our website: http://mcardle.oncology.wisc.edu/farnham.
Because of the immense number of genes dierentially expressed in each pairwise comparison, we used the Absolute Call, a value determined by the expression algorithm, to prioritize our results. On the microarrays, each gene is represented by 20 pairs of 25 oligomers called probe pairs. Each probe pair contains a perfect match and a mismatch oligomer, which is identical to the perfect match except for a mismatched base at the center position. The Absolute Call of present, absent or marginal is based on the number of probe pairs for each gene or EST cluster that showed a positive hybridization signal and the ratio of hybridization to the perfect match and mismatch probes. The Absolute Call is useful for eliminating signals that may be due to nonspeci®c hybridization. We initially focused on those genes considered to be present in each pairwise comparison. Shown in Figure 1a is a Venn diagram representing the number of dierentially expressed genes in each normal sample as compared to the liver tumors. For instance, 162 genes were changed in expression by at least 2.5-fold in the regenerating liver vs liver tumor comparison while 297 genes were dierentially expressed in the newborn vs tumor comparison; 69 genes were dierentially expressed in both the regenerating and newborn livers as compared to liver tumors. Although hundreds of genes were dierentially expressed in a single pairwise comparison, only 22 genes were altered in all three comparisons. The names and fold dierence levels for each of these 22 genes are shown in Table 1a . Although the reliability and reproducibility of data obtained using oligonucleotide microarrays has been previously documented (Coller et al., 2000) , we con®rmed the dierential expression of several of the genes listed in Table 1a using RT ± PCR. For these experiments, seven individual tumors were analysed since each hepatocellular carcinoma arises independently and may present dierent gene expression patterns (Farber, 1976) . Shown in Figure 1b is the dierential expression of seven genes identi®ed as upregulated and four genes identi®ed as downregulated in liver tumors. GAPDH expression was examined in the RNA samples to con®rm equal quantitation (data not shown). The RT ± PCR results were very similar to the oligonucleotide microarray results, therefore, we did not perform RT ± PCR on all 22 genes listed in Table 1a .
In addition to identifying genes which are dierentially regulated in liver tumors as compared to all three normal liver samples, we wanted to identify genes which were signi®cantly dierentially expressed in tumors as compared to the normal quiescent state. Such genes may serve as markers for the altered proliferation characteristic of HCC. Shown in Table 1b is a list of genes which were greater than 10-fold upregulated or downregulated in the liver tumor as compared to the quiescent liver. As noted above, the Absolute Call can be used to eliminate nonspeci®c hybridization signals. However, an absent call may also be made if the expression of an mRNA is extremely low in a sample. Since, in this case, we are interested in identifying mRNAs that are extremely low in quiescent livers, we have included both absent and present genes in Table 1b . We have examined the expression of three highly dierentially expressed genes by RT ± PCR (Figure 1c ). We note that only two of the 16 genes in Table 1b are present in Table 1a , which is most likely due to extremely low expression of those genes in quiescent livers. The results of the RT ± PCR con®rm the dierential expression in quiescent liver versus the liver tumor but also show very little dierential expression when newborn and regenerating livers are compared to the liver tumors.
Finally, we were interested in knowing if liver tumors represent a less dierentiated state. Therefore, we have identi®ed mRNAs which are newborn speci®c and deregulated in the adult liver tumors. In the regenerating vs newborn comparison we identi®ed genes which are newborn-speci®c and not just involved in increased proliferation. Of the 194 mRNAs which are deregulated in the quiescent vs tumor comparison, 88 of them are dierentially expressed in the regenerating vs newborn comparison. Genes such as H19 and insulin-like growth factor binding protein-1 (IGFBP-1) are known to be expressed during fetal development. In this study, both H19 and IGFBP-1 were upregulated in liver tumors and in newborn livers. Other genes that were deregulated in the tumor and newborn liver are CD63, testosterone 16a-hydroxylase and intestinal trefoil factor. These results suggest that the liver tumors are less dierentiated than adult hepatocytes and these genes may be markers of a less dierentiated state.
We also wanted to examine the expression of a few of the most highly deregulated genes in human hepatocellular carcinomas. Using RT ± PCR (Figure 2) , we analysed the expression of CD63, osteopontin (the human homologue of Eta-1), and monokine induced by g interferon (MIG) in HepG2 cells (a hepatoma derived cell line), human hepatocellular adenomas and carcinomas. Signal intensity was normalized to GAPDH in each reaction. The expression of these genes was measured in three individual HCC samples because of the heterogeneity of each tumor. Due to the rarity of adenomas, only one sample was examined. For CD63 and MIG we observed an overall upregulation of expression in both the adenoma and HCCs, but osteopontin was variably upregulated in the three HCCs but not the adenoma. This pattern of upregulated expression in human HCC is similar to the results observed in the mouse liver tumors. These results indicate the relevancy of the DEN mouse model in studying the molecular pro®le of human HCC.
Identification of gene expression alterations in liver tumors by RDA
Although oligonucleotide microarrays provide a rapid means of screening many genes, they are not suitable for detection of rare transcripts and they limit analyses to previously cloned mRNAs. Therefore, we utilized a second technique, RDA, to identify gene expression dierences in tumors. We performed two comparisons between the regenerating livers and liver tumors; in one comparison, the tester was the liver tumor (to identify genes upregulated in liver tumors) and in the other comparison, the regenerating liver was the tester (to identify genes upregulated in regenerating livers). Enrichment of dierence products (DP) was observed after the second round of subtraction and ampli®cation (DP2). We observed no dierence products after the third subtraction and ampli®cation (DP3), perhaps due to the high tester/driver ratio. Consequently, we cloned mRNAs from the DP2 samples. DP2 products that were cloned and sequenced are listed in Table 2 . It has been observed previously that the relative dierence in expression level of a transcript in the tester vs driver usually correlates with the frequency of isolation of that gene by RDA (Welford et al., 1998) . We noted in parentheses the number of times a gene was cloned from our RDA dierence products. We also note that several of the RDA products were also found to be dierentially expressed in the oligonucleotide microarray comparisons (see Table 2 , italics). The fact that several genes were found to dierentially expressed by both RDA and oligonucleotide microarrays demonstrates that the two techniques are complementary. Since RDA has a false positive rate of approximately 10% (Hubank and Schatz, 1999) , it is possible that some of the genes cloned by RDA are not truly dierentially expressed. We felt con®dent that the genes identi®ed by both RDA and the oligonucleotide microarrays were true positives and thus concentrated on con®rming those genes only identi®ed by RDA, especially those genes which were cloned more than once. The expression of genes which were only identi®ed by RDA but cloned multiple times was examined by RT ± PCR ( Figure 3 ). As shown, aurorarelated kinase 1 and the ubiquitin-conjugating enzyme (the mouse homologue of human cyclin-selective ubiquitin carrier) have slightly higher expression in the regenerating liver than the liver tumors, but have undetectable expression in the quiescent livers. This suggests these genes are proliferation speci®c. Serine proteinase inhibitor 2 (SPI-2) was not dierentially expressed and is considered a false positive.
Isolation and expression analysis of a novel cDNA
A unique advantage of RDA is the ability to identify previously uncharacterized genes. We isolated ®ve novel genes using liver tumors as the tester and one gene using the liver tumors as the driver. These novel transcripts have no signi®cant homology to any gene in the NCBI database. However, two of the genes (Figure 4a ). While we observed only modest dierential expression for novel genes 1 and 2, novel genes 3 and 4 were highly dierentially expressed. Novel gene 5 was not dierentially expressed and was considered a false positive. We note that although novel gene 6 showed a slightly higher expression in the regenerating livers than liver tumors, the dierential expression in the quiescent liver vs liver tumors is much more dramatic, suggesting that this gene may be a proliferation marker. We focused on novel gene 4 because it was most highly dierentially expressed and contained a signi®cant ORF. We examined the expression of novel gene 4 in eight mouse tissues and four embryonic stages using a Multiple Tissue cDNA Panel. Gene 4 was most highly expressed in the heart, lung and testis (Figure 4b ). Fairly low expression was seen in the liver sample, a ®nding in agreement with our previous data showing that this gene is normally expressed at low levels in a quiescent liver when compared to a liver tumor. We cloned the mouse cDNA of novel gene 4 by screening a Rapid-Screen Mouse Liver cDNA Library with primers designed from the isolated RDA fragment. A 4.175 kb cDNA was isolated and sequenced and is now called CRG-L1 (cancer related gene ± liver 1). Signi®cant homology to two mouse ESTs (GenBank accession numbers, AW701866 and AW490555) was Figure 2 Expression of highly deregulated genes in human HCC. Expression of CD63, osteopontin, and monokine induced by g interferon by RT ± PCR in normal human liver, hepatocellular adenoma, three independent hepatocellular carcinomas, and HepG2 cells. For each reaction, 100 ng of cytoplasmic RNA was used. Signal intensity was normalized to GAPDH in each reaction Testosterone 15a-hydroxylase (7) Viral envelope like protein (11) Testosterone 16a-hydroxylase (2) Cyclin B1 (6) Apolipoprotein A-IV (2) SPI-2 gene (6) H19 (2) Human Cdc20 (4) Lipoprotein lipase (1) Human cyclin-selective ubiquitin Carboxypeptidase E (1) carrier ( (1) Haptoglobin (1) nimA-related kinase 2 (1) Unknown 6 (1)
Those genes in italics were also found to be dierentially expressed by oligonucleotide microarray comparisons. The number in parentheses refers to the number of times a gene was isolated from the dierence products Figure 3 Con®rmation by RT ± PCR of gene products isolated by RDA. This includes those genes isolated more than one time which were not previously con®rmed using oligonucleotide microarrays. RNA samples were pooled as described in Figure 2 found at the 3' end. CRG-L1 had no signi®cant homology to any gene in the NCBI database. The RDA fragment that was originally cloned from the DP2 products mapped to bases 996 ± 1383 of CRG-L1. A potential ATG translation initiation site (GCGGCCATGG) was found at position 35 with an open reading frame extending to nucleotide 862. The predicted translation contains 275 amino acids with a molecular weight of 31.4 kD (Figure 4d ). To search for any known protein motifs, the protein sequence was analysed by SMART (Simple Modular Architecture Research Tool) (Schultz et al., 1998 (Schultz et al., , 2000 . Seven possible transmembrane domains were found within the protein spanning amino acids 33 ± 53, 62 ± 82, 91 ± 111, 123 ± 143, 146 ± 166, 174 ± 194 and 212 ± 232 . No other known protein motifs have been identi®ed. We also examined the expression of CRG-L1 in normal human liver, a hepatocellular adenoma, HepG2 cells, and three independent HCC samples. We observed a signi®cant increase in expression in each HCC and HepG2 cells when compared to the normal liver (Figure 4e ). The level of expression in the adenoma was slightly less than the HCC levels, suggesting that CRG-L1 expression correlates with malignancy in the liver.
Discussion
The goal of this study is to identify genes that are important in liver tumorigenesis. One problem with the identi®cation of tumor-speci®c genes is the lack of a good non-tumorigenic control. Therefore, we began with a mouse model, which allowed us to compare gene expression between liver tumors and three normal states of proliferation using both oligonucleotide microarrays and representational dierence analysis. This approach has allowed us to identify both known and novel genes involved in dedierentiation, proliferation and neoplasia.
By consideration of the mRNAs that are deregulated by at least 2.5-fold in all three normal samples as compared to tumors and of the mRNAs that are greater than 10-fold dierent in quiescent livers versus liver tumors, we have found several dierent classes of deregulated mRNAs. One category of genes includes liver metabolic enzymes, such as naphthalene hydroxylase, which has been shown previously to be downregulated during mouse hepatocarcinogenesis (Ye et al., 1997; Yamada et al., 1999) . Other liver metabolic genes that we found to be signi®cantly deregulated, such as apolipoprotein A-IV and squalene epoxidase, have not previously been examined in liver cancer. Another category of genes which are deregulated in the mouse hepatocellular carcinomas are involved in cell adhesion and motility. A few of the genes identi®ed in this study have been previously linked to HCC (i.e. H19; Ariel et al., 1998) , and some genes have been previously shown to be deregulated in dierent human cancers. For example, osteopontin (Eta-1 homologue) is upregulated in gastric carcinomas, lung adenocarcinomas, and breast cancer (Tuck et al., 1998; Ue et al., 1998; Shijubo et al., 1999) . In breast cancer, the expression of this protein is correlated with increased invasiveness and decreased survival (Singhal et al., 1997; Tuck et al., 1998 Tuck et al., , 1999 .
It is also of interest to consider mRNAs which were not identi®ed as deregulated in the liver tumors. For example, several genes such as b-catenin, p53 and Rb are known to be mutated within hepatocellular carcinomas (Buendia, 2000) . b-catenin is frequently mutated at the GSK-phosphorylation site in HCC resulting in accumulation of b-catenin protein within the nucleus. Although altered b-catenin mRNA levels would not be expected to be detected by the microarray studies, it was possible that mRNAs from genes that are regulated by b-catenin would have been identi®ed. However, we did not detect an increase in expression of any of the putative b-catenin target genes, such as c-myc. It is possible that some of the genes found to be deregulated in this study are unidenti®ed targets of b-catenin. Alternatively, mutated b-catenin may not aect gene expression but inhibit apoptosis (Chen et al., 2001) . Expression of p53 and Rb may not have been altered in the tumors derived from the DEN-treated mice. Alternatively, proteins highly related to p53 (e.g. p73) and Rb (e.g. p107) may have compensated for such mutations.
To determine if the DEN-treated mice are a good model for HCC, we tested three of the tumor-speci®c genes in human liver tissue samples. We observed upregulated expression of osteopontin, CD63 and MIG. CD63 and MIG were upregulated in both the adenoma and the three carcinomas, but osteopontin was only upregulated in the carcinomas. Therefore, osteopontin may not be a marker of proliferation, but may be an indicator of the metastatic potential of a tumor, similar to breast cancer (Tuck et al., 1999) , which would explain the variable expression of osteopontin in each HCC. MIG is known to be overexpressed in the endothelium of HCC and may be involved in lymphocyte recruitment (Yoong et al., 1999) .
Using RDA, we have also identi®ed ®ve novel genes that are dierentially expressed in liver tumors as compared to at least one normal state of proliferation. We isolated the mouse cDNA of CRG-L1 which contains an open reading frame of 827 bases. Seven putative transmembrane domains have been identi®ed, but no other known protein motifs have been distinguished. CRG-L1 is also upregulated in human hepatocellular adenomas and carcinomas. These results suggest this novel gene may be a critical factor in liver tumor development. Eorts are underway to determine its expression in other human cancers.
In summary, we have identi®ed a number of known and novel genes which are deregulated in murine and human HCC. Importantly, our results indicate that DEN treated mice provide a good model for studying the molecular changes within human HCC. Since studies using human tumors cannot provide information concerning whether the deregulation is an early or late step in carcinogenesis, we plan to examine gene expression in preneoplastic foci in murine livers. These studies will aid in the classi®cation of genes as markers of early or late stages of tumor development. Other future goals are to determine which genes are general tumor markers, which genes are speci®cally expressed in HCC, and which represent early changes in neoplastic transformation. We hope that our results will lead to a better understanding of the cellular pathways involved in tumor progression.
Materials and methods
Mouse husbandry
Inbred C3H/HeJ mice were bred and housed in the McArdle Laboratory Animal Facilities in plastic cages on corncob bedding from Bed-O'Cobs (Anderson Cob Division) and fed Mouse Chow 9F (Purina). Food and acidi®ed water were available ad libitum. To obtain regenerating livers, partial hepatectomies were performed on male, 6-week-old mice as described previously (Lukas et al., 1999) . Animals were sacri®ced 36 h after the surgery, which corresponds to peak DNA synthesis (Bennett et al., 1995) , and the liver remnants were harvested. Quiescent livers were harvested from 6-weekold, male mice. Newborn livers, from both male and female mice, were isolated within 24 h after birth. The liver tumors (hepatomas type A and B) were taken from male mice that were treated with diethylnitrosamine (DEN) (0.1 mM/g body weight) at 12 days of age and sacri®ced at 32 weeks of age.
Human tissue
Human tissue was procured at the University of Wisconsin Surgical Pathology department and through the National Disease Research Interchange. All tissues analysed were primary and noncirrhotic. HCC-2 was hepatitis C positive. As required by our IRB protocol, the identity of the patients was unknown. The excess tissue was frozen after surgery and stored at 7708C.
Preparation of RNA
Total RNA was extracted from liver using guanidine thiocyanate/CsCl as described previously (Lukas et al., 1999) . Poly(A) + mRNA was isolated from 250 mg of total RNA using Oligotex mRNA Kit (Qiagen). For the oligonucleotide microarrays, mRNA was puri®ed twice using Oligotex mRNA Kit (Qiagen) and electrophoresed on a 1% agarose/16MAE buer (50% formamide, 2.2 M formaldehyde, 1 mM 4-morpholinopropanesulfonic acid (MOPS) (pH 7.0), 0.4 M NaOAc, 0.05 mM EDTA) gel to examine for degradation. For oligonucleotide microarray experiments, poly(A) + RNA samples were pooled from eight newborn livers while the quiescent, regenerating and tumor samples were pooled from four livers to avoid mouse-to-mouse variation. HepG2 RNA was made as described previously (Slansky et al., 1993) .
Oligonucleotide microarrays
A complete protocol for converting RNA into`target' for hybridization to microarrays is available at our website: http://mcardle.oncology.wisc.edu/farnham. In brief, twicepuri®ed poly(A) + RNA from quiescent, regenerating and newborn livers, or liver tumors was used to create cDNA with a T7-polyT primer and reverse transcriptase Superscript II (GIBCO/BRL). Approximately 1 mg of cDNA was subjected to in vitro transcription (Ambion) in the presence of biotinylated UTP and CTP (Enzo Diagnostics). The cRNA was fragmented and combined with BSA (0.5 mg/ ml) in a buer containing 26MES, 1.7 M NaCl, 40 mM EDTA and 0.02% Tween 20. Target cRNA (10 mg) was hybridized for 16 h at 408C to each oligonucleotide array (Mu6500 tetraset; Aymetrix) containing probes for more than 6500 murine genes and ESTs. Arrays were washed in the Aymetrix Fluidics Station at 508C with 66SSPE-T (0.9 M NaCl, 60 mM Na 2 HPO 4 , 6 mM EDTA, 0.005% Triton X-100, pH 7.6) then at 408C with 0.56SSPE-T. Arrays were then stained with streptavidin phycoerythrin (Molecular Probes) and washed with 66SSPE-T. Fluorescent intensities were measured with a laser confocal scanner (HewlettPackard) and analysed with GeneChip software (Aymetrix).
Expression analysis by representational difference analysis
The protocol developed by Hubank and Schatz (1994) was followed in detail using polyA RNA from regenerating livers and liver tumors. In the ®rst subtractive round, the representations were hybridized to each other in a 1 : 100 tester/driver ratio. The second and third dierence products used a tester/driver ratio of 1 : 800 and 1 : 400 000 respectively. There were no products visualized by agarose gel in the third dierence products (DP3), so the dierence products were subcloned from DP2 into pBSM13+. Cloned products were sequenced by Big Dye (ABI) in the McArdle Laboratory Sequencing Facility.
RT ± PCR
Each reaction contained 100 ng of cytoplasmic RNA, 16EZ buer (Perkin Elmer), 0.4 M Betaine (Sigma), 60 nM primers, 300 mM dNTPs, 2.5 mM Mn(OAc) 2 and 5U rT th polymerase (Perkin Elmer). After 27 ± 40 cycles of ampli®cation, products were electrophoresed on a 1% agarose gel and visualized by ethidium bromide staining. Details of the primers used for con®rmation of dierentially expressed mRNAs can be found on our website. All primers were synthesized at the UW Biotechnology Center.
Cloning CRG-L1
The mouse cDNA of novel gene 4 was identi®ed from a Rapid-Screen cDNA Mouse Liver Library Panel (Origene) using primers designed to the cDNA fragment cloned by RDA. A Multiple Tissue cDNA Panel (Clontech) was used to analyse expression in multiple mouse tissues. A 4.175 kb cDNA was isolated and sequenced (Genbank Accession AF282864) in both directions by Big Dye (ABI) in the McArdle Laboratory Sequencing Facility.
